Cost-optimized placenta-targeted nanoparticle for localized immune cloaking in recurrent pregnancy loss

Miscarriage is heartbreaking and a growing issue that many families deal with. For some women, it occurs repeatedly for no apparent reason. One of the major causes is thought to be an overreactive immune response, in which the immune system of the mother unintentionally targets the growing fetus. Currently, medications that suppress the entire immune system, also known as immunosuppressive treatments, are occasionally administered to women who have experienced repeated miscarriage. These therapies may have systemic effects on the whole body, can be costly, and put the mother at higher risk of developing serious adverse events. Our study proposes a new, secure option. We recommend using nanoparticles, tiny particles specifically engineered to reach the placenta, and give details regarding the design, safety and efficacy protocols, and the road map to make this product commercially available. Once in place, the nanoparticles can help establish a secure environment where the fetus can grow safely by shielding the fetus from the mothers' immune system. Nanoparticles are a growing treatment option in many fields and can also be used in reproductive medicine to help families who have suffered recurrent miscarriages. In addition, this could decrease the burden of miscarriage on both families and the health care system by improving pregnancy outcomes and reducing the need for dangerous medications.